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HIGHLIGHTS 
 Acute intake of CGAs from coffee impacts on central energetic metabolism. 
 Sustained intake of CGAs from coffee plays a role in microbiota-derived compounds. 
 Trigonelline is a coffee extract beverage biomarker in short- and long-term. 
 Direct excretion of trigonelline would avoid interindividual variation. 
 The use of uni- and multivariate analyses reinforced the biological effects. 
 
ABSTRACT 
Several studies suggest that coffee has some benefits for health; however, little is known about 
the specific role of the main polyphenol compounds of coffee, chlorogenic acids (CGAs), 
without caffeine interaction. A 1H-Nuclear Magnetic Resonance (1H-NMR)-based 
metabolomics approach was used to assess the effect of CGAs from coffee on the human urine 
metabolome. Ten male volunteers participated in a dietary crossover randomized intervention 
study with a rich CGAs coffee extract beverage (CEB: 223 mg/100 ml of CGAs). The study 
consisted of a daily intake of CEB or a control beverage with equal caffeine dose during 28 
days. Fasting urines collected at the first and last days of each period of the study were analyzed 
using an CGAs untargeted 1H-NMR approach. Additionally, 4-hour postpandrial urines after 
the first intake of each beverage were also analyzed. Uni- and multi-variate statistic approaches 
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were used to strengthen the results. Multilevel partial least squares discriminant analysis (ML-
PLS-DA) was used to paired comparisons across the crossover design. A further univariate 
analysis model for crossover studies was performed to assess the significant changes. Acute 
consumption of CEB resulted in high excretion of 2-furoylglycine, likewise endogenous 
compounds such as succinic, citric, 3-methyl-2-oxovaleric and isobutyric acids. Sustained 
consumption of CEB showed an increase of microbiota-derived compounds such as hippuric, 
3-(3-Hydroxyphenyl)-3-hydroxypropionic and 3-hydroxyhippuric acids in urine. Moreover, 
trigonelline was found in urine after both acute and sustained intakes, as well as in the 
composition of the beverage exhibiting a direct excretion of this biomarker without any 
biotransformation, suggesting a non-interindividual variation. 
Abbreviations: CEB, coffee extract beverage; CGAs, chlorogenic acids; FID, free induction 
decay; HPHPA, 3-(3-Hydroxyphenyl)-3-hydroxypropionic acid; LR, loading rank; ML-PLS-
DA, multilevel partial least squares discriminant analysis; NMP, N-methylpyridinium; NMR, 
Nuclear Magnetic Resonance; PCA, principal component analysis; TCA, tricarboxylic acid; 
TSP, 3-(trimethylsilyl)-proprionate-2,2,3,3-d4 
Keywords: Coffee; Chlorogenic acids; Metabolomics; NMR; Biomarkers; Multilevel PLS-DA 
 
1. INTRODUCTION 
Coffee is one of the most widely consumed beverages worldwide, and therefore there are a huge 
number of studies concerning its benefits for health (Cowan, T. E., et al., 2014; Guertin, K. a, 
et al., 2015; R M van Dam & Hu, 2005). Coffee beans contain a large variety of biologically 
active compounds, the predominant ones being chlorogenic acids (CGAs) and caffeine 
(Johnston, Clifford, & Morgan, 2003). Several epidemiological researches suggest that coffee 
consumption may help prevent chronic diseases, including type 2 diabetes mellitus (Van Dam 
& Feskens, 2002), obesity and metabolic syndrome (Nordestgaard, Thomsen, & Nordestgaard, 
2015), Parkinson's disease (Sääksjärvi et al., 2008) and liver disease (La Vecchia, 2005). 
Moreover, coffee is rich in many polyphenols and diterpenes (Urgert & Katan, 1997), which 
have antioxidant properties (Yanagimoto, Ochi, Lee, & Shibamoto, 2004) and may also 
mitigate harmful gut microbiota species with its regular consumption (Cowan et al., 2014). 
Although these beneficial effects are attributed to caffeinated coffee, high intakes of 
decaffeinated coffee have also been associated with a reduced risk of type 2 diabetes mellitus 
(Ding, M., et al., 2014; Huxley, R., et al., 2009) and positive effects on cognition and 
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psychomotor behavior (Shukitt-Hale, Miller, Chu, Lyle, & Joseph, 2013), indicating that some 
compounds in coffee other than caffeine may have a protective effect. Few interventional 
studies focused on the effect of bioactive compounds in coffee in both the short- and long-term 
have been able to provide an explanation for physiological mechanisms. However, in most 
epidemiological studies there is no distinction between caffeinated coffee consumers and newer 
or occasional decaffeinated coffee consumers (Higdon & Frei, 2006). Therefore the role of 
CGAs alone in this beverage is still unclear. 
The application of metabolomics in the nutrition field can provide new information on dietary 
components, with the discovery of new biomarkers of food exposure, thereby revealing 
potential modifications in diet-related pathways in early disease stages likewise in healthy 
individuals (Puiggròs, F., et al., 2015; Scalbert, A., et al., 2014). Nuclear Magnetic Resonance 
(NMR) in metabolomics is a fast, robust, reproducible, non-destructive technique (Wishart, 
2008). Metabolomics allows a global description of metabolites that gives detailed information 
on metabolic pathways and in turn on biological processes, thereby clarifying associations with 
health benefits and elucidating underlying mechanisms (Brennan, 2014). Untargeted 
metabolomics is generally used for the discovery of metabolites and modifications in global 
metabolic pathways, whereas targeted metabolomics is focused on specific metabolic pathways 
(Xu, Wang, Ho, & Ong, 2014). 
Several biomarkers of coffee intake have previously been proposed, including trigonelline, 2-
furoylglycine, caffeine and several polyphenols (Heinzmann, S. S., et al., 2015; Ito, H., et al., 
2005; Lang, R., et al., 2011; Lloyd, A. J., et al., 2013; Rothwell, J. A., et al., 2014; Stalmach, 
A., et al., 2009). Coffee is the main dietary source of CGAs (Clifford, 2000), but although CGAs 
and caffeic acid are the main phenolic compounds identified in urine after coffee intake in short-
term (Ito et al., 2005), derived compounds of polyphenol metabolism are dependent on high 
interindividual variation in humans in long-term because of gut microbiota (Hervert-Hernández 
& Goñi, 2011). 
The present study was conducted to determine whether CGAs from coffee may impact on the 
human urine metabolome through an untargeted metabolomic approach, and to identify the 
changes on the metabolome after both acute and sustained consumptions on healthy human 
volunteers. 
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2. MATERIAL AND METHODS 
2.1. Subjects and study design 
Ten healthy male between 25 and 44 years old with a body mass index of 23.4 ± 2.1 kg/m2 
(mean ± SD) participated in a randomized, double-blind, placebo-controlled, crossover clinical 
trial. Exclusion criteria included caffeine intoxication, intake of CGAs supplements, serious 
illness (such as heart disease, kidney disease or diabetes) and food allergies. The study protocol 
was approved by the Human Research Ethics Committee of Biological Science Laboratories of 
the KAO Corporation (ref: 507-20131218). This clinical trial was registered as International 
Standard Randomized Controlled Trial Number 15516017. 
During the washout and the study periods, the subjects were forbidden to consume coffee and 
tea beverages other than test drink. Subjects were not allowed to consume alcoholic beverages 
and to practice exercise from 2 days before the beginning of the intervention. After a 14-day 
washout period, subjects were asked to consume a coffee extract beverage (CEB) containing 
223 mg/100 ml of CGAs (KAO Corporation, Japan) or a control beverage (caffeine-containing 
beverage). The daily dose of caffeine was similar between the intervention and control groups 
(see Table S1, Supporting information). Then, the participants consumed the corresponding 
beverage every day for the next 28 days (period I). The same procedure was repeated switching 
the individuals between the groups (period II) after a second 14-day washout period, in 
accordance with the crossover design. To analyze acute consumption, urine samples were 
collected during the first 4 postprandial hours after beverage intake on the first day of the 
intervention. For the analysis of sustained consumption, fasting urines on the first and last days 
of each period of the study were collected. All urine samples were stored in aliquots at − 80 °C 
prior to analysis. 
 
2.2. Sample preparation 
Both urine and beverage samples were thawed, vortexed and centrifuged at 13,200 rpm for 5 
min. The supernatant (600 μl) from each sample was mixed with an internal standard solution 
[120 μl, consisting of 0.1% 3-(trimethylsilyl)-proprionate-2,2,3,3-d4 (TSP), chemical shift 
reference), 2 mM of sodium azide (NaN3, bacteriostatic agent) and 1.5 M KH2PO4 in 99% 
deuterium water (D2O)]. The optimized pH of the buffer was set at 7.0, with a potassium 
deuteroxide solution, to minimize variations in the chemical shifts of the NMR resonances. This 
mixture was transferred to a 5 mm NMR tube. 
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2.3. 1H-NMR data acquisition and processing 
The 1H-NMR urinary spectra were acquired on a Varian-Inova-500 MHz NMR spectrometer 
with presaturation of the water resonance using a NOESYPRESAT pulse sequence. During the 
acquisition, the internal temperature was kept constant at 298 K. An exponential window 
function was applied to the free induction decay (FID) with a line-broadening factor of 0.3 Hz 
prior to the Fourier transformation. For each sample, FIDs were collected into 32 K data points, 
128 scans, with a spectral width of 14 ppm, an acquisition time of 2 s, a relaxation delay of 5 s 
and a mixing time of 100 ms (Vázquez-Fresno et al., 2012). 
A CEB sample was acquired on a Bruker Avance III 400 MHz NMR spectrometer equipped 
with a cryoprobe with presaturation of the water resonance using a NOESYPRESAT pulse 
sequence. The internal temperature was kept constant at 298 K and each sample was processed 
with a line-broadening factor of 0.3 Hz, 64 scans with a spectral width of 15 ppm, an acquisition 
time of 3 s, a relaxation delay of 5 s and a mixing time of 10 ms. 
NMR spectra were phased, baseline corrected and referenced (TSP, 0.0 ppm) using TopSpin 
software (version 3.0, Bruker, BioSpin, Germany). After baseline correction, original spectral 
data were bucketed in intelligent bucketing domains of 0.005 ppm with ACD/NMR Processor 
12.0 software (Advanced Chemistry Development, Toronto, Canada). The water signal and the 
regions above 9.5 ppm and below 0.5 ppm were excluded from the analysis. 
 
2.4. Data pre-processing and statistical analysis 
Data from acute and sustained interventions were submitted individually to MetaboAnalyst 3.0 
for filtering and normalization purposes (Xia, Sinelnikov, Han, & Wishart, 2015). To exclude 
data points showing little variance across experimental conditions, the matrix was interquartile 
range filtered. Data were row-wise normalized (rows were samples) by the sum of the 
intensities of the spectra and column-wise normalized (columns were metabolites) using Pareto 
scaling and cube root transformation. Both data sets were used for further statistical analyses. 
All the statistical analyses were performed with R version 3.1.2. Principal component analysis 
(PCA) was performed to detect the presence of outliers and to evaluate a potential carryover 
effect. Multilevel partial least squares discriminant analysis (ML-PLS-DA) was used to paired 
comparisons of the effects of CEB versus control beverage exploiting the crossover design with 
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the R package mixOmics (Lê Cao, González, & Déjean, 2009). ML-PLS-DA is an extension of 
ordinary PLS-DA described by Van Velzen et al. (2008) which allows separation of the within-
subject variation from the inter-subject variation that could obscure nutrition-related metabolic 
effects. A “leave-one-subject-out” cross-validation was performed to assess the ML-PLS-DA 
model and the classification error rate was determined by comparing the predicted class with 
the original one. Discriminant variables were determined based on the minimum value of the 
classification error rate and also on the absolute value of loading scores from the first latent 
variable. Loading scores were ranked and the top 5% of total variables were selected as 
discriminant ones as long as this value was within the range of the minimum classification error 
rate. These variables were used to build a sparse ML-PLS-DA, and the corresponding score 
plot was drawn. On the sparse ML-PLS-DA, the signs were ranked based on the absolute values 
of their loading scores (named loading ranks, LRs), giving the lowest LR-values to signs that 
had the highest loading scores. 
The statistical univariate crossover model (Jones, B. and Kenward, M. G., 2014; Senn, S, 2002) 
of differences between baseline and intervention data was performed between groups to assess 
the statistical significances. In addition to individual effect, period and sequence variables were 
included in the crossover model for further correction on potential carryover effects. Statistical 
significance was considered at a p-value < 0.05. 
 
2.5. Metabolite identification 
Metabolite identification was performed using Chenomx NMR Suite Professional Software 
package (version 8.1; Chenomx Inc., Edmonton, Canada) and by comparing NMR spectral data 
to those available in databases such as the Human Metabolome Database 
(http://www.hmdb.ca), the Biological Magnetic Resonance Data Bank 
(http://www.bmrb.wisc.edu) and the Madison Metabolomics Consortium Database 
(www.mmcd.nmrfam.wisc.edu), along with the existing NMR-based metabolomics literature. 
In addition, quantification of the beverage metabolites was performed with Chenomx using the 
methyl resonance of TSP as an internal standard. Peak fitting with reference to the TSP signal 
allowed quantification of absolute concentrations for the identified compounds. Further, a 
Pearson's correlation test was performed to test the correlation between signals of the same 
metabolite. 
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3. RESULTS AND DISCUSSION 
3.1. 1H-NMR profiling of the coffee extract beverage 
In order to analyze the urine metabolites coming from the coffee beverage, metabolic profiling 
of the CEB was carried out. The identified and quantified metabolites are summarized in Table 
1 and are shown on spectra in Fig. 1. 
 
Table 1. Compounds identified by NMR spectroscopy in the coffee beverage 
(CEB) used in the present study. 
Compound mg/100 ml 
 2-Furoic acid 0.56 
 3-O-Caffeoylquinic acid 48.02 
 4-O-Caffeoylquinic acid 47.03 
 5-O-Caffeoylquinic acid 44.23 
 Acetic acid 20.36 
 Alanine 0.61 
 Caffeic acid 0.43 
 Caffeine 22.65 
 Choline 2.08 
 Citrate 1.75 
 Formic acid 9.45 
 Fumaric acid 0.64 
 Furfuryl alcohol 2.63 
 Lactic acid 3.79 
 Malic acid 22.78 
 Methanol 0.20 
 N-Methylpyridinium –a 
 Nicotinic acid 0.36 
 Myo-inositol 9.52 
 Propionic acid 1.03 
 Sucrose 10.22 
 Quinic acid 15.83 
 Trigonelline 18.83 
a –: identified but not quantified. 
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Fig. 1. 400 MHz 1H-NMR spectra of coffee beverage. 
 
1, trigonelline; 2, formic acid; 3, caffeine; 4, 3-O-caffeoylquinic acid; 5, 4-O-caffeoylquinic acid; 6, 5-O-
caffeoylquinic acid; 7, quinic acid; 8, nicotinic acid; 9, n-methylpyridinium; 10, citric acid; 11, acetic acid; 12, 
lactic acid; 13, propionic acid; 14, fumaric acid; 15, lipids; 16, polysaccharides; 17, choline; 18, myo-inositol; 19, 
malic acid; 20, sucrose; 21, 2-furoic acid; 22, furfuryl alcohol; 23, caffeic acid. 
 
Two furan compounds naturally present in coffee (2-furoic acid and furfuryl alcohol) were 
found in the CEB as precursors of 2-furoylglycine (Heinzmann et al., 2015), a compound found 
in urine after the acute intervention (see Section 3.4). 
N-methylpyridinium (NMP) and nicotinic acid, which were previously described in coffee by 
NMR ( Wei et al., 2012), were observed in the CEB but not detected in urine in this study. NMP 
and nicotinic acid are the main products of trigonelline degradation during pyrolysis and 
roasting (Stadler, Varga, Hau, Arce Vera, & Welti, 2002). We assumed that the low 
concentration of NMP seen in the CEB (Fig. 1) would not be enough to detect this metabolite 
in urine samples in the present study, but it was observed in urine after coffee intake by other 
authors (Lang et al., 2011). 
Caffeine, 3-O-caffeoylquinic, 4-O-caffeoylquinic and 5-O-caffeoylquinic, quinic and caffeic 
acids, which are common compounds in coffee ( Wei et al., 2012), were also found in the CEB. 
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3.2. Evaluation of carryover effects 
PCA was performed to explore the distribution of baseline samples according to the period (I 
and II) and the sequence (control ➔ CEB; or CEB ➔ control; Fig. S1) of the crossover study. 
A point cloud would indicate homogeneity at baseline. Fig. S1 shows that the sample of the 
period I from subject #5 was outside of the point cloud and this may be due to a carryover 
effect. Therefore, all the statistical analyses were performed including and excluding subject 
#5. This subject was included after ruling out biological differences in all analyses without any 
output variation. Accordingly, they did not indicate any carryover effect. However, additional 
correction for period and sequence was included in the univariate statistical crossover models. 
 
3.3. Uni- and multi-variate analyses 
Discriminant metabolites and chemical shifts identified with p-value and LR corresponding to 
uni- and multi-variate, respectively, are presented in Table 2. Fig. 3 presents box plots 
comparing the intensities of significant metabolites between CEB and control beverage. 
The comparison of the differences between interventions resulted in ML-PLS-DA models with 
a minimum classification error rate of 0.1 and 0.0 for sustained and acute interventions, 
respectively (Fig. S2). The lowest rate was 0.1 for a range between the 6th and the 94th variables 
after the sustained intervention, whereas the first discriminant variables after the acute 
intervention were strong enough for keeping the rate to 0 for all variables. The top 5% of loading 
scores were within the range of variables for these classification error rates. Therefore, two 
sparse ML-PLS-DA models were built with them. Fig. 2 presents the sparse ML-PLS-DAs 
which show a clear separation of treatments. The main discriminatory metabolites were 
projected in the first component and the contribution to treatment differences of each sign was 
set in LRs presented in Table 2. 
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Table 2. Metabolites detected in urine after acute and sustained coffee extract beverage 
(CEB) in comparison with control beverage. 
Intervention 
type 
Metabolite δ (multiplicity) 
CBE vs. 
control 
P valuea LRb 
 Acute Trigonelline  9.13 (s) ↑  7.88 × 10−8  4, 5   
 8.84 (d) 
 
 8.44 × 10−7  10, 11, 14   
 8.08 (t) 
 
 1.26 × 10−2  –   
 4.44 (s) 
 
 2.51 × 10−6  15, 25  
 2-Furoylglycine  7.70 (s) ↑  5.90 × 10−4  39   
 7.18 (d) 
 
 9.68 × 10−2  –   
 6.64 (m) 
 
 4.14 × 10−2  –   
 3.93 (d) 
 
 3.00 × 10−4  31, 47  
 Citric acid  2.68 (d) ↑  8.72 × 10−3  –   
 2.54 (d) 
 
 1.31 × 10−3  55  
 Succinic acid  2.41 (s) ↑  7.78 × 10−4  43 
  3-Methyl-2-
oxovaleric acid 
 1.10 (d) ↑  1.35 × 10−3  50  
 0.90 (t) 
 
 1.30 × 10−2  –  
 Isobutyric acid 1.07 (d) ↑  8.91 × 10−3  –   
 2.39 (m) 
 
 2.68 × 10−2  – 
 Sustained Trigonelline  9.13 (s) ↑  1.64 × 10−3  8   
 8.84 (d) 
 
 6.65 × 10−4  7   
 8.08 (t) 
 
 9.54 × 10−3  –   
 4.44 (s) 
 
 9.98 × 10−3  18  
 Hippuric acid  8.53 (s) ↑  2.74 × 10−3  11, 17, 24   
 7.84 (d) 
 
 7.30 × 10−3  –   
 7.64 (t) 
 
 6.66 × 10−5  2, 5, 10   
 7.56 (t) 
 
 8.38 × 10−3  28, 34, 56   
 3.97 (d) 
 
 1.17 × 10−2  22, 35  
 HPHPA  7.31 (t) ↑  2.29 × 10−4  1, 3, 27   
 6.98 (d) 
 
 1.69 × 10−2  –   
 6.91 (s) 
 
 7.40 × 10−3  44, 47   
 6.84 (d) 
 
 2.89 × 10−2  16, 21, 49   
 5.03 (m)c 
 
 –  – 
  3-Hydroxyhippuric 
acid 
 7.40 (t) ↑  1.77 × 10−2  55  
 7.36 (s) 
 
 9.32 × 10−4  6   
 7.28 (s) 
 
 3.18 × 10−1  –   
 7.13 (dd) 
 
 2.42 × 10−2  42   
 4.15 (d) 
 
 3.37 × 10−2  60 
     2.22 (s)   1.94 × 10−2  – 
HPHPA: 3-(3-Hydroxyphenyl)-3-hydroxypropionic acid, s: singlet, d: doublet, t: triplet, dd: double doublet, m: 
multiplet. 
aP-value of univariate statistical crossover model of differences. 
bLoading rank of ML-PLS-DA. 
cSignal not considered because of proximity to water region. 
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Fig. 2. Score plots of the subjects projected onto the first principal components, PC1 and 
PC2, after coffee extract beverage (CEB) in acute (A) and sustained (B) interventions. 
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Fig. 3. Box plots of significant metabolites in urine after coffee extract beverage (CEB) in 
acute (A) and sustained (B) interventions.  
 
2-Fgly: 2-furoylglycine, 3M-2val: 3-methyl-2-oxovaleric acid, Citric: citric acid, Isobut: isobutyric acid, Succ: 
succinic acid, Trig: trigonelline, 3-Hxhipp: 3-hydroxyhippuric acid, Hippur: hippuric acid, HPHPA: 3-(3-
hydroxyphenyl)-3-hydroxypropionic acid. 
 
3.4. Acute intervention 
2-Furoylglycine observed after CBE intake is a product of furan derivatives contained in 
roasting products like coffee (Moon & Shibamoto, 2009) or cocoa (Bonvehí, 2005) conjugated 
with glycine (Ginz, M. and Engelhardt, U. H., 2000 ;  Pettersen, J. E. and Jellum, E., 1972). 
The furan product 2-furoylglycine has been identified after cocoa intake (Garcia-Aloy et al., 
2015) and also associated with coffee intake in epidemiological studies (Guertin et al., 2014). 
Heinzmann and co-workers investigated its excretion kinetics, observing that maximal urinary 
excretion occurred 2 h after the coffee intake, returning to baseline levels after 24 h (Heinzmann 
et al., 2015). It explains its absence in the sustained intervention in the present study. 
The increase of tricarboxylic acid (TCA) cycle intermediates suggests that CGAs coming from 
coffee may affect the central energy metabolism in humans. High levels of isobutyric and 3-
methyl-2-oxovaleric acids were observed. They are products of branched-chain amino acid 
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(BCAA) catabolism: valine and isoleucine, respectively. Both valine (glucogenic BCAA) and 
isoleucine (ketogenic BCAA) are metabolized to succinic acid via the methylmalonyl-CoA 
(Hutson, Sweatt, & LaNoue, 2005) TCA cycle, supported also by a significant higher excretion 
of succinic acid after CEB acute intake. In addition, an increase in the urinary level of citric 
acid was detected, which is also a TCA cycle intermediate, leading to the conclusion that CGAs 
coming from coffee may affect the central energy metabolism in humans, as was seen in a study 
with dietary supplementation with CGAs, which affected the circulating levels of intermediates 
of the TCA cycle in rats (Ruan, Yang, Zhou, Wen, et al., 2014). In accordance with energy 
metabolism, habitual coffee consumption was previously associated with weight control 
(Bakuradze et al., 2011) and a lower risk of type 2 diabetes (R M Van Dam, R. M. and Hu, F. 
B., 2005 ;  Wedick, N. M., et al., 2011). 
 
3.5. Sustained intervention 
Hippuric, 3-hydroxyhippuric and 3-(3-Hydroxyphenyl)-3-hydroxypropionic (HPHPA) acids 
were detected after CEB in comparison with control beverage. These three compounds have 
been observed previously in epidemiological studies after coffee intake (Guertin et al., 2015). 
It has been suggested that CGAs are metabolized by microbiota in the lower gastrointestinal 
tract (Gonthier et al., 2006; M.-P. Gonthier, M.-P., et al., 2003 ;  Ludwig, I. a., et al., 2013), 
obtaining as a product caffeic acid due to cleavage of the ester bond between caffeic and quinic 
acids by an esterase enzyme provided by the colonic microbiota (Plumb et al., 1999). The 
double bond of caffeic acid is reduced to form HPHPA prior to dihydroxylation of 3-(3,4-
dihydroxyphenyl)-propionic acid (Rechner et al., 2004). HPHPA may be absorbed from the 
colon to form hippuric and 3-hydroxyhippuric acids through β-oxidation and glycination in the 
liver (Rechner et al., 2002). Therefore, microbiota metabolites were downstream metabolites 
of 3-O-caffeoylquinic, 4-O-caffeoylquinic and 5-O-caffeoylquinic acids which were detected 
and identified in the CEB (see Section 3.1). Hippuric, 3-hydroxyhippuric and HPHPA acids are 
metabolites of microbiota fermentation of CGAs which are subsequently absorbed in the colon 
(Higdon & Frei, 2006), playing a role in health effects (Williamson & Clifford, 2010) and 
leading to the conclusion that CGAs may have an important function as precursors of 
microbiota-derived compounds observed after sustained consumption. 
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3.6. Common metabolites in urine and the coffee extract beverage 
Trigonelline was identified in urine after intake of the CEB in both acute and sustained 
interventions. According to the results, this metabolite comes from trigonelline naturally 
present in coffee beans (Beans, C., et al., 2009 ;  Guertin, K. a, et al., 2015), as was observed in 
1H-NMR analysis of the CEB (Fig. 1). Lang and co-workers observed this candidate biomarker 
up to three days after coffee consumption (Lang et al., 2011); therefore, trigonelline in the 
sustained intervention could correspond to trigonelline from the previous punctual intake of the 
day before. Thus, according to the results, trigonelline reflects coffee intake of both a punctual 
and a sustained consumption. This metabolite has been proposed as a candidate for dietary 
biomarker coffee intake (Lang, R., et al., 2011 ;  Rothwell, J. A., et al., 2014). Trigonelline was 
also a common metabolite present in urine after both acute and sustained intakes as well as in 
the CEB, indicating a possible direct excretion (without any metabolism occurring) from coffee 
intake, as suggested by K. A. Guertin et al. (2015). A direct excretion of this metabolite suggests 
a non-interindividual variation in the metabolism of this compound, in contrast to microbiota-
derived compounds of polyphenol metabolism, which are dependent on a high interindividual 
variation in humans (Hervert-Hernández & Goñi, 2011). Hence, trigonelline seems to be a 
suitable biomarker of coffee intake after both acute and sustained interventions. 
 
4. CONCLUSIONS 
The results of the current study show the capability of an NMR-based metabolomic approach 
to detect significant changes in urinary metabolite profiling and help to clarify the role of 
specific coffee compounds other than caffeine in human metabolism after both acute and 
sustained interventions. Firstly, the increase of endogenous metabolites related to the TCA 
cycle such as succinic, citric, isobutyric and 3-methyl-2-oxovaleric acids after the acute study 
indicates that coffee CGAs impact on the central energy metabolism. Secondly, the present 
results exhibit two potential CEB biomarkers: 2-furoylglycine, after acute intake, and 
trigonelline, after both acute and sustained CEB intakes. Finally, there are other long-term 
metabolites after sustained intervention coming from the degradation of CGAs by gut 
microbiota observed through the identification of hippuric acid, 3-hydroxyhippuric acid and 
HPHPA. In conclusion, this study shows biomarkers of both short- and long-term intakes of 
coffee products along with other metabolites involved in energy metabolism (after acute intake) 
and microbiota metabolism (after sustained intake). 
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